Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,096 | -15,414 | -16,526 | -11,883 | -7,597 |
| Depreciation Amortization | 6,042 | 2,320 | 2,551 | 1,850 | 1,193 |
| Accounts receivable | 4,892 | -601 | 2,412 | 572 | 2,143 |
| Accounts payable and accrued liabilities | 2,183 | 2,514 | 1,802 | 1,150 | -116 |
| Other Working Capital | -834 | -3,997 | 7,427 | 2,271 | 1,699 |
| Other Operating Activity | 5,578 | 4,631 | 743 | 1,211 | -843 |
| Operating Cash Flow | $-10,235 | $-10,547 | $-1,591 | $-4,829 | $-3,521 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,563 | -1,813 | -3,446 | -1,565 | -912 |
| Net Acquisitions | -113,190 | -113,190 | N/A | N/A | N/A |
| Purchase Of Investment | -86,793 | -15,003 | -59,436 | -56,831 | -40,620 |
| Sale Of Investment | 24,461 | 8,775 | 36,557 | 22,257 | 17,557 |
| Purchase Sale Intangibles | 0 | 0 | -1,240 | -1,043 | -1,148 |
| Other Investing Activity | 0 | 0 | -1,240 | -1,043 | -1,148 |
| Investing Cash Flow | $-180,085 | $-121,231 | $-27,565 | $-37,182 | $-25,123 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 195,212 | 195,212 | N/A | 0 | 0 |
| Common Stock Issued | 3,457 | 2,287 | 5,806 | 3,501 | 2,420 |
| Financing Cash Flow | $198,669 | $197,499 | $5,806 | $3,501 | $2,420 |
| Exchange Rate Effect | 71 | 42 | -38 | -40 | -135 |
| Beginning Cash Position | 35,261 | 35,261 | 58,649 | 58,649 | 58,649 |
| End Cash Position | 43,681 | 101,024 | 35,261 | 20,099 | 32,290 |
| Net Cash Flow | $8,420 | $65,763 | $-23,388 | $-38,550 | $-26,359 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,235 | -10,547 | -1,591 | -4,829 | -3,521 |
| Capital Expenditure | -4,563 | -1,813 | -3,446 | -1,565 | -912 |
| Free Cash Flow | -14,798 | -12,360 | -5,037 | -6,394 | -4,433 |